A Cas9 with PAM recognition for adenine dinucleotides

被引:76
作者
Chatterjee, Pranam [1 ,2 ]
Lee, Jooyoung [3 ]
Nip, Lisa [1 ,2 ]
Koseki, Sabrina R. T. [1 ,2 ]
Tysinger, Emma [1 ,2 ]
Sontheimer, Erik J. [3 ]
Jacobson, Joseph M. [1 ,2 ]
Jakimo, Noah [1 ,2 ]
机构
[1] Ctr Bits & Atoms, Cambridge, MA 02139 USA
[2] MIT, Media Lab, Cambridge, MA 02139 USA
[3] Univ Massachusetts, Sch Med, RNA Therapeut Inst, Worcester, MA USA
基金
美国国家卫生研究院;
关键词
RNA-GUIDED ENDONUCLEASE; GENOMIC DNA; CRISPR; NUCLEASES; BASE; VARIANTS; COMPLEX; CPF1;
D O I
10.1038/s41467-020-16117-8
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
CRISPR-associated (Cas) DNA-endonucleases are remarkably effective tools for genome engineering, but have limited target ranges due to their protospacer adjacent motif (PAM) requirements. We demonstrate a critical expansion of the targetable sequence space for a type II-A CRISPR-associated enzyme through identification of the natural 5-NAAN-3 ' PAM preference of Streptococcus macacae Cas9 (SmacCas9). To achieve efficient editing activity, we graft the PAM-interacting domain of SmacCas9 to its well-established ortholog from Streptococcus pyogenes (SpyCas9), and further engineer an increased efficiency variant (iSpyMac) for robust genome editing activity. We establish that our hybrids can target all adenine dinucleotide PAM sequences and possess robust and accurate editing capabilities in human cells. p id=Par Protospacer adjacent motif (PAM) requirements limit the target range of CRISPR endonucleases. Here, the authors graft the 5 ' -NAAN-3 ' PAM-interacting domain of SmacCas9 onto SpyCas9 to create adenine dinucleotide targeting chimeras.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Catalytic-state structure and engineering of Streptococcus thermophilus Cas9
    Zhang, Yifei
    Zhang, Hongyuan
    Xu, Xuexia
    Wang, Yujue
    Chen, Weizhong
    Wang, Yannan
    Wu, Zhaowei
    Tang, Na
    Wang, Yu
    Zhao, Suwen
    Gan, Jianhua
    Ji, Quanjiang
    NATURE CATALYSIS, 2020, 3 (10) : 813 - +
  • [22] The molecular basis for recognition of 5′-NNNCC-3′ PAM and its methylation state by Acidothermus cellulolyticus Cas9
    Das, Anuska
    Hand, Travis H.
    Smith, Chardasia L.
    Wickline, Ethan
    Zawrotny, Michael
    Li, Hong
    NATURE COMMUNICATIONS, 2020, 11 (01)
  • [23] In Vitro Enzymology of Cas9
    Anders, Carolin
    Jinek, Martin
    USE OF CRISPR/CAS9, ZFNS, AND TALENS IN GENERATING SITE-SPECIFIC GENOME ALTERATIONS, 2014, 546 : 1 - 20
  • [24] Circularly permuted and PAM-modified Cas9 variants broaden the targeting scope of base editors
    Huang, Tony P.
    Zhao, Kevin T.
    Miller, Shannon M.
    Gaudelli, Nicole M.
    Oakes, Benjamin L.
    Fellmann, Christof
    Savage, David F.
    Liu, David R.
    NATURE BIOTECHNOLOGY, 2019, 37 (06) : 626 - +
  • [25] Genome Engineering in Rice Using Cas9 Variants that Recognize NG PAM Sequences
    Hua, Kai
    Tao, Xiaoping
    Han, Peijin
    Wang, Rui
    Zhu, Jian-Kang
    MOLECULAR PLANT, 2019, 12 (07) : 1003 - 1014
  • [26] CRISPR/Cas9 as a Mutagenic Factor
    Shumega, Andrey R.
    Pavlov, Youri I.
    Chirinskaite, Angelina V.
    Rubel, Aleksandr A.
    Inge-Vechtomov, Sergey G.
    Stepchenkova, Elena I.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (02)
  • [27] Switchable Cas9
    Richter, Florian
    Fonfara, Ines
    Gelfert, Renate
    Nack, Jennifer
    Charpentier, Emmanuelle
    Moeglich, Andreas
    CURRENT OPINION IN BIOTECHNOLOGY, 2017, 48 : 119 - 126
  • [28] The domestication of Cas9
    Urnov, Fyodor
    NATURE, 2016, 529 (7587) : 468 - 469
  • [29] Guide RNAs containing universal bases enable Cas9/Cas12a recognition of polymorphic sequences
    Krysler, Amanda R.
    Cromwell, Christopher R.
    Tu, Tommy
    Jovel, Juan
    Hubbard, Basil P.
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [30] Comparison of CRISPR/Cas9 and Cas12a for gene editing in Chlamydomonas reinhardtii
    Ferenczi, Aron
    Fellbaum, Matthew
    Chew, Yen Peng
    Kidner, Catherine
    Molnar, Attila
    ALGAL RESEARCH-BIOMASS BIOFUELS AND BIOPRODUCTS, 2024, 84